ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
ASLN was delisted on the 18th of July, 2024.
7 hedge funds and large institutions have $31M invested in ASLAN Pharmaceuticals Limited American Depositary Shares in 2018 Q2 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Temasek Holdings
Singapore
|
+$11M |
| 2 |
PSCM
Prince Street Capital Management
New York
|
+$5.51M |
| 3 |
HSBC Holdings
London,
United Kingdom
|
+$4.4M |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$3.49M |
| 5 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$2.2M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Temasek Holdings
Singapore
| $12.7M | +$11M | +35,562 | New |
|
|
PSCM
2
Prince Street Capital Management
New York
| $6.33M | +$5.51M | +17,781 | New |
|
|
3
HSBC Holdings
London,
United Kingdom
| $5M | +$4.4M | +14,199 | New |
|
|
4
Baillie Gifford & Co
Edinburgh,
United Kingdom
| $3.96M | +$3.49M | +11,253 | New |
|
|
PIM
5
Platinum Investment Management
Sydney Australia 2000,
Australia
| $2.53M | +$2.2M | +7,112 | New |
|
6
Millennium Management
New York
| $358K | +$315K | +1,016 | New |
|
|
MA
7
MYDA Advisors
Woodmere,
New York
| $195K | +$170K | +548 | New |
|
ASLN Hedge Fund Activity: Q2 2018 in Review
7 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) for Q2 2018, worth a combined $31M.
Buyers outnumbered sellers: 7 funds opened new ASLN positions and 0 closed out — a net gain of 7 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Temasek Holdings, opening a new position worth an estimated $11M.
- 7 institutional investors held ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) as of Q2 2018, up from 0 in Q1 2018.
- Funds reported $31M of ASLAN Pharmaceuticals Limited American Depositary Shares stock for Q2 2018.
- 7 funds opened new ASLAN Pharmaceuticals Limited American Depositary Shares positions in Q2 2018 and 0 closed out, a net change of +7 holders.
- The largest ASLAN Pharmaceuticals Limited American Depositary Shares buyer in Q2 2018 was Temasek Holdings, an estimated $11M added.
Based on aggregated 13F filings for Q2 2018.